Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway

Nianshui Jing, Xinnan Li

DOI: 10.1515/med-2019-0083
Published: 2019-01-01
Container: Open Medicine
Publisher: Walter de Gruyter GmbH
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1515/med-2019-0083,
  title = {Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway},
  author = {Nianshui Jing and Xinnan Li},
  year = {2019},
  journal = {Open Medicine},
  doi = {10.1515/med-2019-0083},
  url = {https://doi.org/10.1515/med-2019-0083}
}

RIS

TY  - JOUR
TI  - Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway
AU  - Nianshui Jing
AU  - Xinnan Li
PY  - 2019
JO  - Open Medicine
DO  - 10.1515/med-2019-0083
UR  - https://doi.org/10.1515/med-2019-0083
ER  -

APA

Jing, N., & Li, X. (2019). Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway. Open Medicine. https://doi.org/10.1515/med-2019-0083

Source records

crossref · retrieved 2026-11-09T10:48:12.675Z